Top compounds associated with response to CLN3


Feature Type Standardized
Nominal ANOVA
mRNA thapsigargin gCSI pan-cancer AAC -0.16 0.005
mRNA BRD-K30748066 CTRPv2 pan-cancer AAC 0.39 0.006
mRNA HBX-41108 CTRPv2 pan-cancer AAC 0.12 0.006
mRNA PD 153035 CTRPv2 pan-cancer AAC 0.12 0.007
mRNA Docetaxel gCSI pan-cancer AAC -0.15 0.007
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.094 0.008
mRNA Methotrexate CTRPv2 pan-cancer AAC -0.1 0.008
mRNA paclitaxel gCSI pan-cancer AAC -0.14 0.008
mRNA KHS101 CTRPv2 pan-cancer AAC 0.1 0.009
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.098 0.01
Download CSV